Close

Reinventing Pharma Commercialization with AI with Faruk Capan

Faruk Capan
Chief Innovation Officer
Β·Eversana

Faruk Capan is Chief Innovation Officer at Eversana, where he is rebuilding pharmaceutical commercialization around AI. He leads the development of an AI-powered platform that replaces slow, manual processes across the drug launch and commercial lifecycle.

Faruk Capan is rethinking how pharmaceutical companies bring products to market by rebuilding the entire commercialization process around AI, data, and personalized engagement. As CEO of Intouch Group, one of the largest health and pharma marketing agencies in the world, Faruk helps drug makers move from mass-market broadcast strategies to precision engagement that reaches the right healthcare providers and patients with the right message at the right time.

In this episode, Russ and Faruk dig into why pharma commercialization has been slow to change, how AI is making it possible to personalize at scale in a highly regulated industry, what the shift from share of voice to share of attention means for how drug companies think about marketing, and why the next competitive advantage in pharma will not come from the molecule but from how it is brought to market.

They also get into the ethics of AI in healthcare marketing, how Faruk thinks about privacy and compliance, the role of data clean rooms and first-party data strategies, and why the agencies that survive the next decade will be the ones that fully embrace AI augmentation rather than treating it as a threat.

Topics Covered:

  • Welcome and intro; Faruk Capan and Intouch Group
  • Why pharma commercialization has been slow to evolve
  • How AI enables personalized engagement at scale in a regulated industry
  • From share of voice to share of attention in healthcare marketing
  • Precision engagement with healthcare providers and patients
  • The ethics of AI in healthcare marketing
  • Privacy, compliance, and data governance in pharma
  • Data clean rooms and first-party data strategies
  • Why the next competitive advantage in pharma is commercialization not the molecule
  • How agencies must evolve to survive the AI era
Close

Stay Up To Date

Be in the know about upcoming industry award programs, nominees, winners, finalists, and judges

Submit
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.